ABOS vs OMC · $73.3M cap vs rev $17.27B
Acumen Pharmaceuticals Inc (ABOS) versus Omnicom Group Inc (OMC) — a side-by-side from cached financials, not a winner call.
Acumen Pharmaceuticals Inc (ABOS) is a biotechnology company listed on US.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
ABOS does not have a complete income-statement cache yet.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
ABOS currently screens at market cap $73.3M. OMC currently screens at market cap $21.75B.
Not investment advice. Open the ABOS and OMC stock pages for the full models.
Not investment advice.